TERUMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,724 JPY | -2.56% |
|
+3.67% | +17.85% |
| May. 15 | Correction: Terumo’s Profit Up 47% in Fiscal 2024 | MT |
| May. 15 | Terumo’s Profit Up 47% in Fiscal 2023 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 922B 5.92B | Sales 2025 * | 971B 6.23B | Capitalization | 4,044B 25.97B |
|---|---|---|---|---|---|
| Net income 2024 | 106B 683M | Net income 2025 * | 124B 794M | EV / Sales 2024 | 4.4 x |
| Net Debt 2024 * | 23.33B 150M | Net cash position 2025 * | 54.26B 348M | EV / Sales 2025 * | 4.11 x |
| P/E ratio 2024 |
38.2
x | P/E ratio 2025 * |
32.8
x | Employees | 30,207 |
| Yield 2024 |
0.81% | Yield 2025 * |
0.91% | Free-Float | 95.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Terumo Corporation
More recommendations
More press releases
More news
| 1 day | -2.56% | ||
| 1 week | +3.67% | ||
| Current month | +1.11% | ||
| 1 month | +5.79% | ||
| 3 months | -0.78% | ||
| 6 months | +15.43% | ||
| Current year | +17.85% |
1 week
2 612.00
2 816.50
1 month
2 550.502 816.50
Current year
2 267.003 014.50
1 year
1 856.003 014.50
3 years
1 708.003 014.50
5 years
1 440.003 014.50
10 years
490.253 014.50
| Managers | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 66 | 81-03-31 |
Naoki Muto
DFI | Director of Finance/CFO | - | - |
Kazuhisa Senshu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shouji Hatano
CMP | Compliance Officer | 64 | 83-03-31 |
Hidenori Nishi
BRD | Director/Board Member | 73 | 20-06-24 |
Shinjiro Sato
BRD | Director/Board Member | 63 | 04-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 32 M€ | +15.54% | ||
| 1.94% | 28,258 M€ | +16.92% | - | |
| 1.90% | 15,324 M€ | +15.88% | - | |
| 1.82% | 64,792 M€ | +16.79% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 2,724 | -2.56% | 4,163,300 |
| 24-05-16 | 2,795 | +3.14% | 4,606,200 |
| 24-05-15 | 2,710 | +1.71% | 4,225,000 |
| 24-05-14 | 2,664 | +0.04% | 3,748,100 |
| 24-05-13 | 2,664 | +1.39% | 2,329,500 |
Delayed Quote Japan Exchange, May 17, 2024 at 02:00 am EDT
More quotes
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-08-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,724
JPY
Average target price
2,992
JPY
Spread / Average Target
+9.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.85% | 26.02B | |
| -5.43% | 181B | |
| +4.30% | 114B | |
| -3.09% | 68.29B | |
| +5.86% | 52.24B | |
| +8.15% | 44.3B | |
| +7.52% | 42.73B | |
| +25.54% | 32.52B | |
| +1.00% | 25.91B | |
| -1.25% | 24.72B |
- Stock Market
- Equities
- 4543 Stock
